Edwards Lifesciences Cost of Goods Sold 2010-2024 | EW

Edwards Lifesciences annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Edwards Lifesciences cost of goods sold for the quarter ending September 30, 2024 was $0.263B, a 4.91% increase year-over-year.
  • Edwards Lifesciences cost of goods sold for the twelve months ending September 30, 2024 was $1.477B, a 34.86% increase year-over-year.
  • Edwards Lifesciences annual cost of goods sold for 2023 was $1.38B, a 27.71% increase from 2022.
  • Edwards Lifesciences annual cost of goods sold for 2022 was $1.08B, a 13.49% decline from 2021.
  • Edwards Lifesciences annual cost of goods sold for 2021 was $1.249B, a 15.57% increase from 2020.
Edwards Lifesciences Annual Cost of Goods Sold
(Millions of US $)
2023 $1,380
2022 $1,080
2021 $1,249
2020 $1,081
2019 $1,114
2018 $939
2017 $875
2016 $797
2015 $617
2014 $626
2013 $517
2012 $491
2011 $490
2010 $408
2009 $399
Edwards Lifesciences Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $263
2024-06-30 $285
2024-03-31 $386
2023-12-31 $543
2023-09-30 $251
2023-06-30 $257
2023-03-31 $330
2022-12-31 $258
2022-09-30 $254
2022-06-30 $269
2022-03-31 $299
2021-12-31 $310
2021-09-30 $312
2021-06-30 $334
2021-03-31 $293
2020-12-31 $296
2020-09-30 $281
2020-06-30 $238
2020-03-31 $265
2019-12-31 $286
2019-09-30 $292
2019-06-30 $304
2019-03-31 $232
2018-12-31 $235
2018-09-30 $225
2018-06-30 $246
2018-03-31 $234
2017-12-31 $235
2017-09-30 $213
2017-06-30 $211
2017-03-31 $216
2016-12-31 $213
2016-09-30 $201
2016-06-30 $203
2016-03-31 $180
2015-12-31 $176
2015-09-30 $147
2015-06-30 $159
2015-03-31 $136
2014-12-31 $160
2014-09-30 $168
2014-06-30 $151
2014-03-31 $146
2013-12-31 $144
2013-09-30 $128
2013-06-30 $124
2013-03-31 $121
2012-12-31 $122
2012-09-30 $112
2012-06-30 $130
2012-03-31 $127
2011-12-31 $120
2011-09-30 $126
2011-06-30 $128
2011-03-31 $117
2010-12-31 $114
2010-09-30 $96
2010-06-30 $100
2010-03-31 $99
2009-12-31 $102
2009-09-30 $99
2009-06-30 $102
2009-03-31 $97
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $41.569B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $196.322B 23.95
Intuitive Surgical (ISRG) United States $195.140B 102.02
Alcon (ALC) Switzerland $42.414B 28.38
IQVIA Holdings (IQV) United States $36.630B 20.18
IDEXX Laboratories (IDXX) United States $34.166B 40.24
DexCom (DXCM) United States $28.447B 42.84
Waters (WAT) United States $22.175B 32.79
STERIS (STE) Ireland $21.157B 24.36
SONOVA HOLDING (SONVY) Switzerland $20.795B 0.00
Hologic (HOLX) United States $18.343B 19.35
Fresenius Medical Care AG KGaA (FMS) Germany $13.004B 13.35
Sysmex ADR (SSMXY) Japan $12.946B 0.00
Globus Medical (GMED) United States $11.536B 29.21
Penumbra (PEN) United States $9.397B 92.04
Masimo (MASI) United States $9.260B 44.81
Teleflex (TFX) United States $8.904B 14.20
Glaukos (GKOS) United States $7.940B 0.00
PROCEPT BioRobotics (PRCT) United States $4.884B 0.00
Integer Holdings (ITGR) United States $4.632B 26.26
Veracyte (VCYT) United States $3.068B 92.07
Inari Medical (NARI) United States $2.907B 0.00
LivaNova (LIVN) United Kingdom $2.787B 16.09
TransMedics (TMDX) United States $2.552B 80.89
Nihon Kohden (NHNKY) Japan $2.480B 18.84
Elekta AB (EKTAY) Sweden $2.167B 17.66
Tandem Diabetes Care (TNDM) United States $2.023B 0.00
Integra LifeSciences Holdings (IART) United States $1.820B 9.51
RxSight (RXST) United States $1.807B 0.00
Alphatec Holdings (ATEC) United States $1.427B 0.00
Artivion (AORT) United States $1.185B 78.53
Pulse Biosciences (PLSE) United States $1.088B 0.00
OPKO Health (OPK) United States $1.078B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.855B 14.53
Paragon 28 (FNA) United States $0.841B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.723B 0.00
IRadimed (IRMD) United States $0.675B 36.46
OrthoPediatrics (KIDS) United States $0.638B 0.00
Mesa Laboratories (MLAB) United States $0.593B 13.97
AxoGen (AXGN) United States $0.587B 0.00
SiBone (SIBN) United States $0.527B 0.00
Pacific Biosciences Of California (PACB) United States $0.493B 0.00
Treace Medical Concepts (TMCI) United States $0.488B 0.00
Semler Scientific (SMLR) United States $0.463B 31.05
Tactile Systems Technology (TCMD) United States $0.428B 23.18
CVRx (CVRX) United States $0.360B 0.00
ClearPoint Neuro (CLPT) United States $0.326B 0.00
Delcath Systems (DCTH) United States $0.312B 0.00
NeuroPace (NPCE) United States $0.290B 0.00
AngioDynamics (ANGO) United States $0.278B 0.00
Inogen (INGN) United States $0.223B 0.00
Sight Sciences (SGHT) United States $0.204B 0.00
Accuray (ARAY) United States $0.194B 0.00
Nevro (NVRO) United States $0.169B 0.00
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.146B 15.60
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
908 Devices (MASS) United States $0.089B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
Vicarious Surgical (RBOT) United States $0.068B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.060B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
Rapid Micro Biosystems (RPID) United States $0.049B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Accelerate Diagnostics (AXDX) United States $0.041B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Biosig Technologies (BSGM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Neuronetics (STIM) United States $0.027B 0.00
NexGel (NXGL) United States $0.023B 0.00
Spectral AI (MDAI) United States $0.022B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
Autonomix Medical (AMIX) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00